Sungwon Lim
Sungwon Lim is the CEO and Co-Founder of ImpriMed, Inc., which uses artificial intelligence on live cancer cell analytics to predict how a patient will respond to cancer therapy drugs before taking them. Sungwon received his PhD degree in Bioengineering from Stanford University and a master’s degree in Translational Medicine…